Pharmaceuticals

PTMG Autumn Conference 2018

AA Thornton returns to PTMG in Dubrovnik! Consulting Patent Attorney Julie Barrett-Major  and Trade Mark Attorney Suzanne Power represented the firm at the Autumn Pharmaceutical Trade Marks Group (PTMG) conference in Dubrovnik, Croatia from 3rd to 6th October 2018. Julie and Susie hosted a tea and round table event at the Hotel Croatia Cavtat just before the start of… Read more »

Protection for cannabis-based IP

Protection for cannabis-based IP in the wake of announcement of impending legalisation of medicinal cannabis The legalisation of medicinal and recreational cannabis in several US states, Canada and some European countries has resulted in a new economic market rising from what was previously an illegal trade. Meanwhile, in the UK, the recent cases of Billy… Read more »

EU: Falsified Medicines Directive: Implications for parallel importers and of Brexit

EU: Falsified Medicines Directive: Implications for parallel importers and of Brexit This article was updated: 8 October 2018 Introduction to the Falsified Medicines Directive Directive 2011/62/EU, better known as “The Falsified Medicines Directive” or “FMD”, came into force on 2 January 2013, with the aim of preventing falsified medicines from entering the legitimate supply chain… Read more »

WIPO Magazine has announced the launch of a new tool linking patents and drugs: Pat-INFORMED

WIPO Magazine has announced[1] the launch of a new tool linking patents and drugs: Pat-INFORMED The concept The World Intellectual Property Organization (WIPO) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), together with 20 participating global pharmaceutical companies, have joined forces to globalise the concept of the US’s ‘Orange Book’. Most drugs have… Read more »

Assessment of “plausibility” requirement from the EPO perspective

Assessment of “plausibility” requirement from the EPO perspective Introduction This article considers how the EPO views the requirement of “plausibility”, which can arise during both the assessment of “sufficient disclosure” of the invention and “inventive step” in proceedings before the EPO, particularly in relation to inventions in the Pharmaceuticals and Life Sciences field. The EPO… Read more »

Swiss Biotech Day 2018

Swiss Biotech Day 2018, Basel, Switzerland Patent Attorneys Dr Craig Turner  and Julie Barrett- Major represented the firm at the Swiss Biotech Day 2018, in Basel, Switzerland, on 3 May 2018. According to European Biotechnology Magazine, “with more than 600 senior executives from the Swiss life science industry and from across Europe the annually held was as popular as… Read more »

CRISPR: the gene editing tool and related patents

CRISPR: the gene editing tool and related patents CRISPR (clustered regularly interspaced short palindromic repeats) gene-editing technology is considered as one of the biggest innovations of the century in the biotechnology field and has gained a lot of attention worldwide, especially in the US and Europe in the area of Intellectual Property Rights. Research has… Read more »

Relaxing the tension between Publishing and Patenting: The Legal Basis for Tension – Part One

Relaxing the tension between Publishing and Patenting: The Legal Basis for Tension – Part One In the summer of 1975, at a Medical Research Council (MRC) meeting, a presentation was given by scientists César Milstein and Georges Köhler.1 The topic: monoclonal antibodies. The presentation was attended by Tony Vickers, a member of the MRC, who… Read more »

CPhI’s 7th Annual Pharma IPR Conference in Mumbai, India

Patent Attorneys Geoff Hussey, Craig Turner, Alex Bone and Leonita Paulraj are attending CPhI’s 7th Annual Pharma IPR Conference in Mumbai, India from 7th-9th March. Craig and Geoff will also be speaking about the implications of Brexit on Indian pharma companies on the 8th March. CPhI’s 7th Annual Pharma IPR Conference is a leading platform… Read more »

Categories

Archives